Compound 1758
Identifiers
- Canonical SMILES:
NS(=O)(=O)c1ccc(OCCCN2CCC(CC2)[C@@](O)(C2CCCC2)c2ccccn2)cc1
- IUPAC name:
4-(3-{4-[cyclopentyl(hydroxy)pyridin-2-ylmethyl]piperidin-1-yl}propoxy)benzenesulfonamide
- InChi:
InChI=1S/C25H35N3O4S/c26-33(30,31)23-11-9-22(10-12-23)32-19-5-16-28-17-13-21(14-18-28)25(29,20-6-1-2-7-20)24-8-3-4-15-27-24/h3-4,8-12,15,20-21,29H,1-2,5-7,13-14,16-19H2,(H2,26,30,31)/t25-/m0/s1
- InChiKey:
NQXVDDGKDJESCO-VWLOTQADSA-N
External links
![]() 73010398 |
![]() CHEMBL3126199 |
2SE |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MENIN / MLL | 6.94 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 473.23 g/mol | |||
HBA | 7 | |||
HBD | 3 | |||
HBA + HBD | 10 | |||
AlogP | 2.71 | |||
TPSA | 105.75 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5636 | Dianicline | DB12125 | |
0.4777 | Hydroquinine | DB13718 | |
0.4777 | Hydroquinidine | DB15300 | |
0.4610 | Ibutilide | DB00308 | |
0.4573 | SCH-486757 | DB12782 | |
0.4549 | GLPG-0187 | DB12297 | |
0.4540 | ZK-806711 | DB03373 | |
0.4520 | 1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM | DB04763 | |
0.4518 | Quinine | DB00468 | |
0.4518 | Quinidine | DB00908 | |
0.4508 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid | DB07189 | |
0.4478 | 18-methoxycoronaridine | DB15096 | |
0.4444 | Quinisocaine | DB13683 | |
0.4438 | Bepotastine | DB04890 | |
0.4429 | Tramadol | DB00193 |